Quick Answer
Perspective Therapeutics, Inc. reported Stockholders Equity of $207.03 million for the year ending 2025.
- Perspective Therapeutics, Inc. showed a decrease of -28.8% in Stockholders Equity from 2024 to 2025.
- This data is from Perspective Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2011 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2013: $5.37 million | Q3 2013: $7.41 million | Q4 2013: $6.49 million | Q1 2014: $24.65 million | Q3 2014: $23.42 million | Q4 2014: $22.53 million | Q1 2015: $21.60 million | Q3 2015: $19.84 million | Q4 2015: $18.55 million | Q1 2016: $17.52 million | Q3 2016: $14.97 million | Q4 2016: $13.57 million | Q1 2017: $12.25 million | Q3 2017: $9.15 million | Q4 2017: $7.87 million | Q1 2018: $6.62 million | Q3 2018: $11.11 million | Q4 2018: $9.67 million | Q1 2019: $8.61 million | Q3 2019: $6.96 million | Q4 2019: $6.14 million | Q1 2020: $5.82 million | Q3 2020: $5.10 million | Q4 2020: $12.77 million | Q1 2021: $68.10 million | Q3 2021: $65.76 million | Q4 2021: $64.39 million | Q1 2022: $63.20 million | Q3 2022: $57.70 million | Q1 2023: $118.03 million | Q2 2023: $108.65 million | Q3 2023: $98.77 million | Q1 2024: $229.89 million | Q2 2024: $341.00 million | Q3 2024: $328.47 million | Q1 2025: $284.65 million | Q2 2025: $265.69 million | Q3 2025: $242.22 million.
- Over the full 16 years of available data (2011 to 2025), Perspective Therapeutics, Inc.'s Stockholders Equity has grown by 3,108.5%.
- Historical annual values: Fiscal year 2025: $207.03 million | Fiscal year 2024: $290.67 million | Fiscal year 2023: $75.18 million | Fiscal year 2022: $54.64 million | Fiscal year 2022: $61.28 million | Fiscal year 2021: $67.41 million | Fiscal year 2020: $5.72 million | Fiscal year 2019: $7.68 million | Fiscal year 2018: $5.03 million | Fiscal year 2017: $10.60 million | Fiscal year 2016: $16.40 million | Fiscal year 2015: $20.78 million | Fiscal year 2014: $23.96 million | Fiscal year 2013: $5.37 million | Fiscal year 2012: $5.82 million | Fiscal year 2011: $6.45 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: